Cysteine-rich protein 61 (CCN1) and connective tissue growth factor (CCN2) at the crosshairs of ocular neovascular and fibrovascular disease therapy.
about
Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilaritiesInterplay between CCN1 and Wnt5a in endothelial cells and pericytes determines the angiogenic outcome in a model of ischemic retinopathy.The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.The matricellular protein CCN1 controls retinal angiogenesis by targeting VEGF, Src homology 2 domain phosphatase-1 and Notch signaling.Single and Compound Knock-outs of MicroRNA (miRNA)-155 and Its Angiogenic Gene Target CCN1 in Mice Alter Vascular and Neovascular Growth in the Retina via Resident MicrogliaCCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathyDegradome products of the matricellular protein CCN1 as modulators of pathological angiogenesis in the retina.Molecular control of vascular development by the matricellular proteins CCN1 (Cyr61) and CCN2 (CTGF).A perspective on the role of the extracellular matrix in progressive retinal degenerative disorders.Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions.Emerging roles of CCN proteins in vascular development and pathology.Abscisic acid: an antiangiogenic phytohormone that modulates the phenotypical plasticity of endothelial cells and macrophages.Analysis of CCN Protein Expression and Activities in Vasoproliferative Retinopathies.Recombinant CCN1 prevents hyperoxia-induced lung injury in neonatal rats.
P2860
Q26782080-A11AA0D5-68E7-423D-8D99-9ABB516187FBQ33684492-72FA1589-6B36-4877-B102-E2ADA53D9FA7Q35586224-CDABFA6A-4116-4BA4-A86D-87DEBD2E2848Q35877484-BC4553C0-39CF-49AF-AB84-320EEA4B176EQ36281635-D5531F6D-4754-42C4-8158-36F2D0E29099Q36369272-C1790E59-30E3-4601-AFEE-1448F0DB9949Q37095390-AA2AD473-404F-4390-8FEF-87BD3FD06C78Q37707888-24E1614D-4E93-4C20-BAAB-57239D8E0037Q38171998-60B3A132-D9C5-4FC8-8C6C-90FF08459D2CQ38258015-EE6EDC41-E4D2-426E-B356-686D30B25AECQ38848476-52CBBE23-E967-4066-9FD3-34D8E71A1AB8Q48183508-456DBF53-CC7B-4F61-B6CB-57A948380910Q48480284-0AD77674-E905-4B48-AF89-9277BB713DBFQ50895121-2E783DDC-42A7-4A7E-80AC-473B7EF0809D
P2860
Cysteine-rich protein 61 (CCN1) and connective tissue growth factor (CCN2) at the crosshairs of ocular neovascular and fibrovascular disease therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cysteine-rich protein 61 (CCN1 ...... fibrovascular disease therapy.
@en
Cysteine-rich protein 61
@nl
type
label
Cysteine-rich protein 61 (CCN1 ...... fibrovascular disease therapy.
@en
Cysteine-rich protein 61
@nl
prefLabel
Cysteine-rich protein 61 (CCN1 ...... fibrovascular disease therapy.
@en
Cysteine-rich protein 61
@nl
P2860
P1476
Cysteine-rich protein 61 (CCN1 ...... fibrovascular disease therapy.
@en
P2093
Brahim Chaqour
P2860
P2888
P304
P356
10.1007/S12079-013-0206-6
P577
2013-06-07T00:00:00Z